Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial. Eur Heart J Acute Cardiovasc Care. 2017 Mar; 6(2):155-163.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Female
Hemorrhage
Humans
Lactones
Male
Middle Aged
Platelet Aggregation Inhibitors
Pyridines
Secondary Prevention
Treatment Outcome

authors with profiles

Robert Harrington